{"transactions":[{"id":924771,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":68205,"kind":"person","name":"Haring-Layton MarDee","position":1,"cik":"0001535596","reported_name":"Haring-Layton MarDee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-02-02T21:05:49.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":49000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer."}],"balance_after":49000,"derivative":{"exercise_price":1.81,"expiration_date":"2036-01-30","underlying":"Common stock","underlying_shares":49000},"source":{"system":"sec-edgar","filing":"0001535596-26-000002","document":"wk-form4_1770066346.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000153559626000002/wk-form4_1770066346.xml","form_type":"4"}},{"id":1047744,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":68205,"kind":"person","name":"Haring-Layton MarDee","position":1,"cik":"0001535596","reported_name":"Haring-Layton MarDee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-09-04T21:59:23.000Z","date":"2025-09-04","kind":"grant","planned":false,"acquired":true,"shares":57000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was granted to the reporting person as a retention award and vests and becomes exercisable on 9/4/2027, provided, that, if certain performance criteria are satisfied, it will vest and become exercisable on the date such performance criteria are satisfied, subject to the reporting person's continuous service to the issuer."}],"balance_after":57000,"derivative":{"exercise_price":2.13,"expiration_date":"2035-09-04","underlying":"Common stock","underlying_shares":57000},"source":{"system":"sec-edgar","filing":"0001401914-25-000046","document":"wk-form4_1757023159.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191425000046/wk-form4_1757023159.xml","form_type":"4"}},{"id":1289339,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":68205,"kind":"person","name":"Haring-Layton MarDee","position":1,"cik":"0001535596","reported_name":"Haring-Layton MarDee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-01-31T22:34:13.000Z","date":"2025-01-28","kind":"grant","planned":false,"acquired":true,"shares":38000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer."}],"balance_after":38000,"derivative":{"exercise_price":3.27,"expiration_date":"2035-01-28","underlying":"Common stock","underlying_shares":38000},"source":{"system":"sec-edgar","filing":"0001401914-25-000006","document":"wk-form4_1738362847.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191425000006/wk-form4_1738362847.xml","form_type":"4"}},{"id":1576476,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":68205,"kind":"person","name":"Haring-Layton MarDee","position":1,"cik":"0001535596","reported_name":"Haring-Layton MarDee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-03-14T20:28:11.000Z","date":"2024-03-12","kind":"grant","planned":false,"acquired":true,"shares":290000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer."}],"balance_after":290000,"derivative":{"exercise_price":0.46,"expiration_date":"2034-03-12","underlying":"Common stock","underlying_shares":290000},"source":{"system":"sec-edgar","filing":"0001401914-24-000004","document":"wk-form4_1710448076.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000140191424000004/wk-form4_1710448076.xml","form_type":"4"}}]}